Combination of Neostigmine and Glycopyrrolate + I-Box by Dynatronics for neurogenic bowel

A treatment and a condition, followed through the public trial records. Not medical advice. How a status is set

Phase 3 trial. Large late-stage trial in people. As of 19 Nov 2026, from 1 registered trial.

Why this status

  1. 6 Nov 2020: Trial started, NCT06351995
  2. 8 Apr 2024: Trial registered, NCT06351995

The trials

NCT06351995: Neostigmine and Glycopyrrolate by Iontophoresis

State
Under way
Phase
Phase 3
People
6 taking part
Started
6 Nov 2020
Primary completion
25 Oct 2022
Arms
Primary
Results
None posted
  1. 6 Nov 2020: Trial started
  2. 8 Apr 2024: Trial registered

How the status changed

  1. 19 Nov 2026: First set: Phase 3 trial

Registries searched: ClinicalTrials.gov, through 17 Nov 2026.